X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (111) 111
female (92) 92
male (92) 92
cardiovascular (82) 82
index medicus (66) 66
ezetimibe (59) 59
middle aged (58) 58
cholesterol (53) 53
aged (50) 50
cholesterol, ldl - blood (41) 41
drug therapy, combination (37) 37
treatment outcome (37) 37
double-blind method (36) 36
statins (36) 36
risk factors (34) 34
anticholesteremic agents - therapeutic use (32) 32
simvastatin (31) 31
adolescent (29) 29
cardiac & cardiovascular systems (29) 29
adult (28) 28
hypercholesterolemia (28) 28
lipids (28) 28
azetidines - therapeutic use (27) 27
coronary-heart-disease (26) 26
hypercholesterolemia - drug therapy (26) 26
atorvastatin (25) 25
child (25) 25
low density lipoproteins (25) 25
abridged index medicus (24) 24
cardiovascular disease (24) 24
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (24) 24
simvastatin - therapeutic use (24) 24
drug therapy (23) 23
azetidines - administration & dosage (21) 21
anticholesteremic agents - administration & dosage (19) 19
children (19) 19
atorvastatin calcium (18) 18
nutrition & dietetics (18) 18
statin (18) 18
cardiovascular-disease (17) 17
child, preschool (17) 17
simvastatin - administration & dosage (17) 17
care and treatment (16) 16
diabetes (16) 16
hypercholesterolemia - blood (16) 16
time factors (16) 16
analysis (15) 15
coronary heart disease (15) 15
health aspects (15) 15
pharmacology & pharmacy (15) 15
cardiovascular diseases (14) 14
efficacy (14) 14
ldl-c (14) 14
medicine, general & internal (14) 14
statin therapy (14) 14
heptanoic acids - therapeutic use (13) 13
internal medicine (13) 13
obesity (13) 13
peripheral vascular disease (13) 13
pyrroles - therapeutic use (13) 13
secondary prevention (13) 13
acute coronary syndromes (12) 12
clinical-trials (12) 12
dosage and administration (12) 12
hypercholesterolemia - complications (12) 12
low density lipoprotein (12) 12
metabolic syndrome (12) 12
pediatrics (12) 12
prevention (12) 12
acute coronary syndrome - drug therapy (11) 11
antilipemic agents (11) 11
biomarkers - blood (11) 11
cardiology (11) 11
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (11) 11
lipid-altering efficacy (11) 11
research (11) 11
retrospective studies (11) 11
rosuvastatin (11) 11
safety (11) 11
anticholesteremic agents - adverse effects (10) 10
atherosclerosis (10) 10
clinical trials (10) 10
dose-response relationship, drug (10) 10
double-blind (10) 10
dyslipidemia (10) 10
endocrinology & metabolism (10) 10
follow-up studies (10) 10
heptanoic acids - administration & dosage (10) 10
lipids - blood (10) 10
lipoproteins (10) 10
low-density lipoprotein cholesterol (10) 10
medicine, research & experimental (10) 10
myocardial-infarction (10) 10
placebo-controlled trial (10) 10
pyrroles - administration & dosage (10) 10
triglycerides (10) 10
young adult (10) 10
aged, 80 and over (9) 9
azetidines - adverse effects (9) 9
biochemistry & molecular biology (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 68, Issue 16, pp. C136 - C137
  Objectives The ACC/AHA 2013 cholesterol guidelines do not specify lipid target levels, but rather treatment of patients classified by cardiovascular risk to... 
Cardiovascular | Internal Medicine | Low density lipoproteins | Statins | Atherosclerosis | Diabetes | Low density lipoprotein | Patients
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 25, pp. 2387 - 2397
In this trial, patients with an acute coronary syndrome within the previous 10 days were randomly assigned to simvastatin plus either ezetimibe or placebo. At... 
CHOLESTEROL ABSORPTION | CARDIAC OUTCOMES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | EFFICACY | CARDIOVASCULAR OUTCOMES | CLINICAL-TRIALS | SIMVASTATIN | PRIMARY PREVENTION | IMPROVE-IT | ATORVASTATIN | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Liver | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2016, Volume 67, Issue 25, pp. 3025 - 3026
  In response to Drs. Mascitelli and Goldstein, we previously reported in the primary publication of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin... 
Anticholesteremic Agents | Cardiovascular Diseases | Hypercholesterolemia | Humans | Simvastatin | Ezetimibe | Cholesterol, LDL | Secondary Prevention | Drug Therapy, Combination | Acute coronary syndromes | Mortality | Clinical outcomes
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 68, Issue 3, pp. 326 - 326
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 67, Issue 25, pp. 3025 - 3026
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 66, Issue 16, pp. C228 - C229
  Objectives Elevated remnant-lipoprotein cholesterol (RLP-C) levels are associated with an increased risk of ischemic heart disease. 
Cardiovascular | Internal Medicine | Cholesterol | Methods | Blood lipids | Agreements
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2016, Volume 68, Issue 3, p. 326
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2016, Volume 67, Issue 25, pp. 3025 - 3026
Journal Article
Biostatistics (Oxford, England), ISSN 1465-4644, 07/2019, Volume 20, Issue 3, pp. 499 - 516
Low-density lipoprotein cholesterol (LDL-C) has been identified as a causative factor for atherosclerosis and related coronary heart disease, and as the main... 
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2016, Volume 68, Issue 16, pp. C136 - C137
Journal Article
American Heart Journal, ISSN 0002-8703, 2014, Volume 168, Issue 2, pp. 205 - 212.e1
Journal Article